In line with this concept, Notch3 has been recognized as a pivotal driver required for survival and maintenance of NSCLC CSCs both in humans and mice [74], and recent findings indicate that Notch3 silencing inhibits EMT, decreases tumor cell proliferation, and induces apoptosis in NSCLC cells [14]. Here, NOTCH3 is linked to neoplasm.